(MENAFN- America News Hour) Research Nester published a report titled
“Vitamin K2 Market: Global Demand Analysis & Opportunity Outlook 2035”
which delivers a detailed overview of the global vitamin K2 market in terms of market segmentation by type, source, application, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, and supply and demand risk, along with a detailed discussion of current and future market trends that are associated with the growth of the market.
The global vitamin K2 market is anticipated to grow with a CAGR of ~26% over the forecast period, i.e., 2022-2035. The market is segmented by application into nutraceuticals, food, and pharmaceuticals, out of which, the nutraceuticals segment is anticipated to hold a significant share by 2031 on account of an increasing number of cases of vitamin deficiency.
Get a Sample PDF Brochure:
The global vitamin K market is estimated to touch a revenue of USD 700 million by the end of 2035, up from a revenue of USD 450 million by the end of 2021. The growth of the market is on the back of increasing cases of osteoporosis and arthritis, an increase in health consciousness, and consumer demand for nutritional supplements during the forecast period. Osteoporosis leads to 3 fractures every second causing 8.9 million fractures across the world, as per the International Osteoporosis Foundation.
Additionally, the rise in aesthetic standards and an increase in consumption of vitamin K2 to prevent calcium deficiency contribute to the growth of the market during the forecast period. Vitamin K2 is essential for the body to utilize calcium and build healthy strong bones.
The global vitamin K2 market is segmented by region into five major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. The market in North America region is estimated to witness noteworthy growth over the forecast period on the back of increasing use of herbal medicines.
In February 2010, the US announced a new Global Health Initiative that invest an amount of USD 63 billion over 6 years to help partner countries improve healthcare outcomes.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players' competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Browse the full report summary:
Increasing Patient Pool Suffering from Vitamin Deficiency to Drive the Market Growth
An increase in aesthetic standards and consumption of vitamin K2 to stop calcium deficiency attribute to the growth of the market during the forecast period.
Every year, the national incidence of VKDB (vitamin K deficiency bleeding) in people who have not received prophylaxis at birth is 1 per 100,000 births.
Intake of vitamin K2 supplements for anticoagulation therapy and arthritis disease is estimated to attribute to the market growth during the forecast period. Further, the rise in healthcare prices and rising demand from pharmaceutical industries, food and beverage industries, and cosmetic companies attribute to the growth of the market in this region. Also, increasing growth of the geriatric population, rising health concerns, and an increasing patient pool with vitamin deficiency.
It is suggested that the lifetime risk of fracture can be reduced by 25% with daily usage of vitamin K supplements.
However, regulations for nutraceuticals and issues related to expiry dates are expected to operate as key restraints to the growth of the global vitamin K2 market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global vitamin K2 market which includes company profiling of Kappa Bioscience Group, Gnosis by Lesaffre, Koninklijke DSM N.V., Viridis BioPharma Pvt. Ltd., DuPont, Seebio Biotech (Shanghai) Co., Ltd, Geneferm Biotechnology Co., Ltd., Kyowa Hakko Bio Co., Ltd, International Flavors & Fragrances Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global vitamin K2 market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Get a PDF Sample For More Detailed Market Insights:
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email:
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919